Cargando…

Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial

OBJECTIVE: Management of heavily pre-treated platinum-resistant ovarian cancer remains a therapeutic challenge. Outcomes are poor with non-platinum, single-agent chemotherapy (CT); however, molecularly targeted anticancer therapies provide new options. METHODS: This open-label, investigator-initiate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jung-Yun, Kim, Byoung-Gie, Kim, Jae-Weon, Lee, Jung Bok, Park, Eunhyang, Joung, Je-Gun, Kim, Sunghoon, Choi, Chel Hun, Kim, Hee Seung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250853/ https://www.ncbi.nlm.nih.gov/pubmed/35320892 http://dx.doi.org/10.3802/jgo.2022.33.e45

Ejemplares similares

Phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer: primary analysis in the original cohort of KGOG3046/TRU-D
por: Park, Junsik, et al.
Publicado: (2023)

A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D
por: Lee, Jung-Yun, et al.
Publicado: (2019)

A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive, recurrent ovarian cancer patients previously treated with a PARP inhibitor: Korean Gynecologic Oncology Group (KGOG 3056)/NIRVANA-R trial
por: Park, Junsik, et al.
Publicado: (2021)

Real-World Experience of Pembrolizumab Monotherapy in Patients with Recurrent or Persistent Cervical Cancer: A Korean Multi-Center Retrospective Study (KGOG1041)
por: Choi, Min Chul, et al.
Publicado: (2020)

Discrepancy between Cytology and Histology in Cervical Cancer Screening: a Multicenter Retrospective Study (KGOG 1040)
por: Ouh, Yung-Taek, et al.
Publicado: (2021)

The 5th Shanghai Gynecologic Oncology Group (SGOG)-Korean Gynecologic Oncology Group (KGOG) joint meeting and 2016 Asia-Pacific Ovarian cancer Laparotomy and Laparoscopic Operation (APOLLO) symposium in Shanghai
por: Chang, Ha Kyun, et al.
Publicado: (2016)

Comparisons of survival outcomes between bevacizumab and olaparib in BRCA-mutated, platinum-sensitive relapsed ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG 3052)
por: Kim, Se Ik, et al.
Publicado: (2021)

Prognostic Model for Survival and Recurrence in Patients with Early-Stage Cervical Cancer: A Korean Gynecologic Oncology Group Study (KGOG 1028)
por: Paik, E Sun, et al.
Publicado: (2020)

Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4
por: Kim, Yoo-Na, et al.
Publicado: (2023)

An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021)
por: Lee, Shin-Wha, et al.
Publicado: (2018)

A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)
por: Lee, Yong Jae, et al.
Publicado: (2021)

Benign Metastasizing Leiomyoma with Multiple Lymph Node Metastasis: A Case Report
por: Yoon, Gun, et al.
Publicado: (2011)

Real-World Experience of Olaparib Maintenance in High-Grade Serous Recurrent Ovarian Cancer Patients with BRCA1/2 Mutation: A Korean Multicenter Study
por: Paik, E Sun, et al.
Publicado: (2019)

Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer
por: Lee, Yong Jae, et al.
Publicado: (2022)

Health outcomes, education, healthcare delivery and quality – 3045: Questionnaire survey of patients with allergic disorders in Bangalore, India
por: Hoskote, Eash, et al.
Publicado: (2013)

Cost–utility analysis for platinum-sensitive recurrent ovarian cancer therapy in South Korea: results of the polyethylene glycolated liposomal doxorubicin/carboplatin sequencing model
por: Lee, Hwa-Young, et al.
Publicado: (2013)

Ambit stochastics
por: Barndorff-Nielsen, Ole E, et al.
Publicado: (2018)

Managing ambition
por: Wilcox, Martin
Publicado: (2013)

An abundance of ambition
por: Cowen, Gemma
Publicado: (2020)

Opportunity and Ambition
Publicado: (1915)

The Fatal Ambition
Publicado: (1871)

Robotic high para-aortic lymph node dissection with high port placement using same port for pelvic surgery in gynecologic cancer patients
por: Kim, Tae-Joong, et al.
Publicado: (2015)

Phase II Study of Combination Chemotherapy with Etoposide and Ifosfamide in Patients with Heavily Pretreated Recurrent or Persistent Epithelial Ovarian Cancer
por: Kang, Heeseok, et al.
Publicado: (2009)

Nomograms Predicting Platinum Sensitivity, Progression-Free Survival, and Overall Survival Using Pretreatment Complete Blood Cell Counts in Epithelial Ovarian Cancer
por: Paik, E Sun, et al.
Publicado: (2017)

A prospective randomized controlled trial evaluating the safety and efficacy of patient blood management program in patients with gynecologic cancer (KGOG 4011/PBM)
por: Park, Jeong-Yeol, et al.
Publicado: (2023)

A Bishop's Ambition
Publicado: (1889)

A Challenge, an Ambition
por: Cotter, José
Publicado: (2015)

An Iowa Girl’s Ambition
Publicado: (1882)

Pattern of practice for postoperative management of endometrial cancer in Korea: a survey by the Korean Gynecologic Oncology Group and the Korean Radiation Oncology Group (KGOG 2028-KROG 2104)
por: Lee, Sung Uk, et al.
Publicado: (2023)

Extrauterine epithelioid trophoblastic tumor in hysterectomized woman
por: Kim, Ji-Hye, et al.
Publicado: (2017)

Randomized comparison between sentinel lymph node mapping using indocyanine green plus a fluorescent camera versus lymph node dissection in clinical stage I-II endometrial cancer: a Korean Gynecologic Oncology Group trial (KGOG2029/SELYE)
por: Park, Jeong-Yeol, et al.
Publicado: (2022)

Controversies in the management of endometrial cancer: a survey of the Korean Gynecologic Oncology Group
por: Lee, Jung-Yun, et al.
Publicado: (2015)

Modulated electro-hyperthermia with weekly paclitaxel or cisplatin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: The KGOG 3030 trial
por: Kim, Kidong, et al.
Publicado: (2021)

Retroperitoneal Approach in Single-Port Laparoscopic Hysterectomy
por: Kim, Tae-Hyun, et al.
Publicado: (2016)

Primary ovarian choriocarcinoma mimicking ectopic pregnancy
por: Heo, Eun Jin, et al.
Publicado: (2014)

Thymosin β(10) Expression Driven by the Human TERT Promoter Induces Ovarian Cancer-Specific Apoptosis through ROS Production
por: Kim, Young-Chae, et al.
Publicado: (2012)

Clinical outcomes of primary surgical treatment for acquired vulvar lymphangioma circumscriptum
por: Yoon, Gun, et al.
Publicado: (2015)

Metastatic Skin Lesions on Lower Extremities in a Patient with Recurrent Serous Papillary Ovarian Carcinoma: A Case Report and Literature Review
por: Kim, Moon-Kyung, et al.
Publicado: (2012)

Megaprojects and risk: an anatomy of ambition
por: Flyvbjerg, Bent
Publicado: (2003)

A Laudable Ambition, etc.
Publicado: (1888)

Cannot write session to /tmp/vufind_sessions/sess_d1hpeou1p5sil2ffvbv5md6sq3